PNPLA3 I148M polymorphism and progressive liver disease

• The 148 Isoleucine to Methionine protein variant (I148M) of patatin-like phospholipase domain-containing 3 (PNPLA3), a protein is expressed in the liver and is involved in lipid metabolism, has recently been identified as a major determinant of liver fat content. Several studies confirmed that the I148M variant predisposes towards the full spectrum of liver damage associated with fatty liver: from simple steatosis to steatohepatitis and progressive fibrosis. Furthermore, the I148M variant represents a major determinant of progression of alcohol related steatohepatitis to cirrhosis, and to influence fibrogenesis and related clinical outcomes in chronic hepatitis C virus hepatitis, and possibly chronic hepatitis B virus hepatitis, hereditary hemochromatosis and primary sclerosing cholangitis. All in all, studies suggest that the I148M polymorphism may represent a general modifier of fibrogenesis in liver diseases. Remarkably, the effect of the I148M variant on fibrosis was independent of that on hepatic steatosis and inflammation, suggesting that it may affect both the quantity and quality of hepatic lipids and the biology of non-parenchymal liver cells besides hepatocytes, directly promoting fibrogenesis. Therefore, PNPLA3 is a key player in liver disease progression. Assessment of the I148M polymorphism will possibly inform clinical practice in the future, whereas the determination of the effect of the 148M variant will reveal mechanisms involved in hepatic fibrogenesis. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Nyckelord

Alcoholic liver disease

Chronic hepatitis C virus hepatitis

Fibrogenesis

Genetics

Hepatocellular

CHRONIC HEPATITIS-C

DOMAIN-CONTAINING 3

GENOME-WIDE ASSOCIATION

B-VIRUS INFECTION

GREATER-THAN-G

FATTY LIVER

INSULIN-RESISTANCE

HEPATOCELLULAR-CARCINOMA

NONALCOHOLIC STEATOHEPATITIS

GENETIC VARIANT

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)